MA35021B1 - Composition à base d'huile ozonisée destinée à une utilisation topique - Google Patents

Composition à base d'huile ozonisée destinée à une utilisation topique

Info

Publication number
MA35021B1
MA35021B1 MA36296A MA36296A MA35021B1 MA 35021 B1 MA35021 B1 MA 35021B1 MA 36296 A MA36296 A MA 36296A MA 36296 A MA36296 A MA 36296A MA 35021 B1 MA35021 B1 MA 35021B1
Authority
MA
Morocco
Prior art keywords
wounds
composition
composition based
topical use
ozonized oil
Prior art date
Application number
MA36296A
Other languages
English (en)
Inventor
Primo Tortini
Ascentiis Alessia De
Original Assignee
Neovalis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neovalis S R L filed Critical Neovalis S R L
Publication of MA35021B1 publication Critical patent/MA35021B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un dispositif médical de désinfection ayant une activité topique améliorée dans le procédé de régénération d'ulcères et de blessures, et dans la résolution d'états inflammatoires. Cette composition comprend une quantité efficace d'une huile ozonisée et une quantité efficace d'une huile essentielle extraite de camomille. La présente invention concerne également les utilisations de ladite composition dans le secteur cosmétique et pharmaceutique. La composition de l'invention est spécialement utile dans la désinfection et la cicatrisation des lésions cutanées telles que les blessures, les abrasions, les ulcères aigus ou chroniques, et les plaies de différentes origines et de différentes natures.
MA36296A 2011-03-07 2012-03-07 Composition à base d'huile ozonisée destinée à une utilisation topique MA35021B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000354A ITMI20110354A1 (it) 2011-03-07 2011-03-07 Composizione a base di olio ozonizzato per uso topico
PCT/IB2012/051057 WO2012120454A1 (fr) 2011-03-07 2012-03-07 Composition à base d'huile ozonisée destinée à une utilisation topique

Publications (1)

Publication Number Publication Date
MA35021B1 true MA35021B1 (fr) 2014-04-03

Family

ID=43977024

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36296A MA35021B1 (fr) 2011-03-07 2012-03-07 Composition à base d'huile ozonisée destinée à une utilisation topique

Country Status (7)

Country Link
EP (1) EP2683356A1 (fr)
KR (1) KR20140071956A (fr)
BR (1) BR112013022891A2 (fr)
IT (1) ITMI20110354A1 (fr)
MA (1) MA35021B1 (fr)
MX (1) MX2013010275A (fr)
WO (1) WO2012120454A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9403181B2 (en) * 2013-07-26 2016-08-02 Paul O'Malley Oral care product formulation
EP3139738B1 (fr) * 2014-05-07 2019-11-27 Multiossigen S.P.A. Produit d'activation des mécanismes de défense chez les plantes
US20170182204A1 (en) * 2014-09-02 2017-06-29 Deniz TANYOLAC A bioactive tissue repairing layer
ITUB20155024A1 (it) * 2015-11-24 2017-05-24 Dario Apuzzo Nuova composizione nutraceutica, somministrabile per via orale, per la prevenzione o trattamento di stati infiammatori e dolorifici delle vie aeree superiori.
IT201600111171A1 (it) * 2016-11-04 2018-05-04 Uras Cosmetics S R L S Kit per il trattamento della pelle e suo impiego
TR201804452A2 (tr) * 2018-03-29 2018-06-21 Ahmet Uemit Sabanci Ozonlanmiş yağ i̇çeren solüsyonlar
IT201800009621A1 (it) * 2018-10-19 2020-04-19 Roberto Soldati Composizione fitoterapica ozonizzata per la rigenerazione tissutale e ossea
IT201800009679A1 (it) * 2018-10-22 2020-04-22 Giorgio Mezzoli Metodo per modificare l’odore dell’olio ozonizzato
EP3949980A1 (fr) 2020-08-04 2022-02-09 Vassiliki Griva Compositions pour le traitement de la dermatite atopique contenant des huiles ozonisées et des agents antioxydants naturels

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1255660B (de) 1964-06-08 1967-12-07 Dr Klaus Gaebelein Verfahren zur Herstellung von Glykolaethergruppen enthaltenden Acetalperoxiden
US5183911A (en) 1986-03-01 1993-02-02 Dr. J. Hansler Gmbh Process for the production of stable ozonized oils from unsaturated vegetable oils
RU2008898C1 (ru) * 1992-08-26 1994-03-15 Геннадий Иванович Суколин Способ лечения грибковых и вирусных заболеваний кожи и/или ногтевых пластинок
FR2784388B1 (fr) * 1998-10-07 2003-06-27 Bernard Sonnois Huile ozonisee obtenue par generateur alimente en oxygene pur - huile saturee en ozone
ES2162586B1 (es) 1999-11-25 2002-07-01 Moraleda Manuel Gomez Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
CU23467A1 (es) * 2002-04-08 2009-12-17 Cnic Ct Nac Investigaciones Procedimiento para la obtención de aceites y grasas vegetales ozonizados para fines farmacéuticos y cosmetológicos
ECSP034481A (es) * 2003-02-14 2004-09-28 Jacome Neptali Rene Cristobal Ordonez Proceso de produccion de crema estable de ozono a partir de aceites vegetales insaturados y equipo utilizado
GB2402066B (en) 2003-05-23 2006-06-07 Bioquell Uk Ltd Apparatus for disinfecting a surface
AR051429A1 (es) * 2004-04-20 2007-01-17 Stenti De Pirillo Haydee A Composicion farmaceutica ozonizada y metodos para obtenerla
WO2006021924A1 (fr) 2004-08-26 2006-03-02 Pieter Josua Le Roux Huile therapeutique
ITRM20050514A1 (it) * 2005-10-17 2007-04-18 Gabriele Maietta Olio ozonizzato, principio attivo di elevata stabilita' a base di perossidi utilizzabile per applicazioni terapeutiche mediche e per trattamenti domiciliari similari a quelli dell'ozonoterapia, senza l'utilizzo di ozono gassoso.
GB0521873D0 (en) * 2005-10-27 2005-12-07 Karim Steven Pure 03 serums
BE1017155A3 (nl) 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
EP2213165A1 (fr) * 2007-11-27 2010-08-04 Erc Technology Inc. Nouvelles compositions contenant un agent tensio-actif ozonisé
EP2149598A1 (fr) * 2008-07-31 2010-02-03 Sanipan S.r.l. Procédé de fabrication d'un véhicule à base d'huile ozonée

Also Published As

Publication number Publication date
WO2012120454A1 (fr) 2012-09-13
BR112013022891A2 (pt) 2016-08-16
KR20140071956A (ko) 2014-06-12
ITMI20110354A1 (it) 2012-09-08
MX2013010275A (es) 2014-03-31
EP2683356A1 (fr) 2014-01-15

Similar Documents

Publication Publication Date Title
MA35021B1 (fr) Composition à base d'huile ozonisée destinée à une utilisation topique
Chang et al. Strategy for treatment of infected diabetic foot ulcers
Preshaw Host modulation therapy with anti‐inflammatory agents
Kanzaki et al. Pathways that regulate ROS scavenging enzymes, and their role in defense against tissue destruction in periodontitis
Corsini et al. Role of oxidative stress in chemical allergens induced skin cells activation
Fumakia et al. Nanoparticles encapsulated with LL37 and serpin A1 promotes wound healing and synergistically enhances antibacterial activity
Nanjundaiah et al. Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk
El-Shinnawi et al. Associations between periodontitis and systemic inflammatory diseases: response to treatment
Fosang et al. Drug insight: aggrecanases as therapeutic targets for osteoarthritis
BR112012018500A2 (pt) alguns inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso destas
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
BR112012032193A2 (pt) composto, composiçoes e métodos de uso de feniltioacetato
BR112012027034A2 (pt) inibidores da arginase e suas aplicações terapêuticas
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
EA201490396A1 (ru) Ингибиторы репликации вирусов гриппа
EA201391786A1 (ru) Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2
EA201500394A1 (ru) Ингибиторы деметилаз гистонов
BR112014009415A2 (pt) inibidores de arginase e suas aplicações terapêuticas
EA201000797A1 (ru) Аминотриазолы в качестве ингибиторов pi3k
EA201190042A1 (ru) Имидазопиразиновые ингибиторы тирозинкиназы syk
CL2012003401A1 (es) Compuestos derivados de carbamato de hexafluoroisopropilo, inhibidores de la enzima monoacil glicerol lipasa (mgl); proceso de preparacion; medicamento; compuestos intermediarios; composicion farmaceutica; y su uso para tratar o prevenir dolores agudos o cronicos, vertigos, dislipidemias y epilepsia, entre otras enfermedades.
MA34474B1 (fr) Agonistes de gpr40
EA200870218A1 (ru) Замещенные имидазольные производные, композиции и способы применения в качестве ингибиторов ртразы
MA44948A1 (fr) Inhibiteurs de bace 1
Kim et al. Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway